参考文献
【注1】 Kolata G, A cancer conundrum: too many drug trials, too few patients. The New York Times, Aug 12, 2017.
【注2】 Borghaei H, et al., Nivolumab versus Docetaxel in advanced nonsquamous non-small-cell lung cancer. New Engl J Med 373: 1627-1639, 2015.
【注3】 Bonfill X, et al., Second-line chemotherapy for non-small cell lung cancer. Cochrane Database Syst Rev CD002804, 2002.